$4.90
0.357.69%
At close: -
$4.92
0.020.31%
After Hours: Dec 24, 2:43 PM EDT
Corvus Pharma reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Corvus Pharma using advanced sorting and filters.
Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Sep 2024 | 2024-11-12 | $-0.60 | $-0.11 | -445.5 % |
Jun 2024 | 2024-08-06 | $-0.07 | $-0.12 | 41.7 % |
Mar 2024 | 2024-05-06 | $-0.12 | $-0.11 | -9.09 % |
Dec 2023 | 2024-03-19 | $-0.14 | $-0.12 | -16.7 % |
Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Corvus Pharma (CRVS) is scheduled to report earnings on March 18, 2025. The last reported earnings were for reported on November 12, 2024 for Q3.
The Actual EPS was $-0.60, which missed the estimate of $-0.11.
The Actual Revenue was $0K, which hit the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.